期刊
JOURNAL OF NEUROINFLAMMATION
卷 16, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12974-019-1567-4
关键词
Blood markers; Neuroinflammation; Neurodegeneration; Alzheimer's disease; Neurofilament light chain; Amyloid-beta; Kynurenine pathway; Brain amyloid-beta; Blood amyloid-beta
资金
- Anglicare, Sydney
- Australian Alzheimer's Research Foundation (AARF), Perth
- KaRa Institute of Neurological Diseases (KaRa MINDS), Sydney
- Swedish Research Council [2018-02532]
- European Research Council [681712]
- Swedish State Support for Clinical Research [ALFGBG-720931]
- Cooperative Research Centre for Mental Health top-up scholarship
Background: Blood markers indicative of neurodegeneration (neurofilament light chain; NFL), Alzheimer's disease amyloid pathology (amyloid-beta; A beta), and neuroinflammation (kynurenine pathway; KP metabolites) have been investigated independently in neurodegenerative diseases. However, the association of these markers of neurodegeneration and AD pathology with neuroinflammation has not been investigated previously. Therefore, the current study examined whether NFL and A beta correlate with KP metabolites in elderly individuals to provide insight on the association between blood indicators of neurodegeneration and neuroinflammation. Methods: Correlations between KP metabolites, measured using liquid chromatography and gas chromatography coupled with mass spectrometry, and plasma NFL and A beta concentrations, measured using single molecule array (Simoa) assays, were investigated in elderly individuals aged 65-90 years, with normal global cognition (Mini-Mental State Examination Score >= 26) from the Kerr Anglican Retirement Village Initiative in Ageing Health cohort. Results: A positive correlation between NFL and the kynurenine to tryptophan ratio (K/T) reflecting indoleamine 2, 3-dioxygenase activity was observed (r=.451, p <.0001). Positive correlations were also observed between NFL and kynurenine (r=.364, p <.0005), kynurenic acid (r=.384, p <.0001), 3-hydroxykynurenine (r=.246, p=.014), anthranilic acid (r=.311, p=.002), and quinolinic acid (r=.296, p=.003). Further, significant associations were observed between plasma A beta 40 and the K/T (r=.375, p <.0005), kynurenine (r=.374, p <.0005), kynurenic acid (r=.352, p <.0005), anthranilic acid (r=.381, p <.0005), and quinolinic acid (r=.352, p <.0005). Significant associations were also observed between plasma A beta 42 and the K/T ratio (r=.215, p=.034), kynurenic acid (r=.214, p=.035), anthranilic acid (r=.278, p=.006), and quinolinic acid (r=.224, p=.027) in the cohort. On stratifying participants based on their neocortical A beta load (NAL) status, NFL correlated with KP metabolites irrespective of NAL status; however, associations between plasma A beta and KP metabolites were only pronounced in individuals with high NAL while associations in individuals with low NAL were nearly absent. Conclusions: The current study shows that KP metabolite changes are associated with biomarker evidence of neurodegeneration. Additionally, the association between KP metabolites and plasma A beta seems to be NAL status dependent. Finally, the current study suggests that an association between neurodegeneration and neuroinflammation manifests in the periphery, suggesting that preventing cytoskeleton cytotoxicity by KP metabolites may have therapeutic potential.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据